{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T04:17:26Z","timestamp":1792297046534,"version":"4.4.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T00:00:00Z","timestamp":1754092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T00:00:00Z","timestamp":1754092800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["F30 AI181286"],"award-info":[{"award-number":["F30 AI181286"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01 AI173318"],"award-info":[{"award-number":["R01 AI173318"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["T32 HL170967"],"award-info":[{"award-number":["T32 HL170967"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-22-1-0036"],"award-info":[{"award-number":["W81XWH-22-1-0036"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Microb Cell Fact"],"DOI":"10.1186\/s12934-025-02800-2","type":"journal-article","created":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T03:43:05Z","timestamp":1754106185000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Limosilactobacillus reuteri enables oral-to-systemic absorption of iberiotoxin for treatment of collagen-induced arthritis in rats"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1568-6394","authenticated-orcid":false,"given":"Mohamed R.","family":"Kady","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6855-9476","authenticated-orcid":false,"given":"R. Nicholas","family":"Elston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8173-0367","authenticated-orcid":false,"given":"Lauren J.","family":"Snyder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7243-3950","authenticated-orcid":false,"given":"Jorie D.","family":"Fleischman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-0475-0748","authenticated-orcid":false,"given":"Madilyn J.","family":"Brandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8048-2171","authenticated-orcid":false,"given":"Duolong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8983-9539","authenticated-orcid":false,"given":"Robert A.","family":"Britton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2500-5874","authenticated-orcid":false,"given":"Christine","family":"Beeton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,2]]},"reference":[{"key":"2800_CR1","doi-asserted-by":"publisher","first-page":"18001","DOI":"10.1038\/nrdp.2018.1","volume":"4","author":"JS Smolen","year":"2018","unstructured":"Smolen JS, Aletaha D, Barton A, Burmester GR, Emery P, Firestein GS, et al. Rheumatoid arthritis. Nat Rev Dis Primers. 2018;4:18001.","journal-title":"Nat Rev Dis Primers"},{"key":"2800_CR2","doi-asserted-by":"publisher","first-page":"243","DOI":"10.2310\/6620.2009.09010b","volume":"20","author":"M Bremmer","year":"2009","unstructured":"Bremmer M, Deng A, Gaspari AA. A mechanism-based classification of dermatologic reactions to biologic agents used in the treatment of cutaneous disease: part 2. Dermatitis. 2009;20:243\u201356.","journal-title":"Dermatitis"},{"key":"2800_CR3","doi-asserted-by":"publisher","first-page":"4014","DOI":"10.1074\/jbc.M111.312264","volume":"287","author":"X Hu","year":"2012","unstructured":"Hu X, Laragione T, Sun L, Koshy S, Jones KR, Ismailov II, et al. KCa1.1 potassium channels regulate key proinflammatory and invasive properties of fibroblast-like synoviocytes in rheumatoid arthritis. J Biol Chem. 2012;287:4014\u201322.","journal-title":"J Biol Chem"},{"key":"2800_CR4","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nrrheum.2012.190","volume":"9","author":"N Bottini","year":"2013","unstructured":"Bottini N, Firestein GS. Duality of fibroblast-like synoviocytes in RA: passive responders and imprinted aggressors. Nat Rev Rheumatol. 2013;9:24\u201333.","journal-title":"Nat Rev Rheumatol"},{"key":"2800_CR5","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13075-018-1783-9","volume":"21","author":"MR Tanner","year":"2019","unstructured":"Tanner MR, Pennington MW, Chauhan SS, Laragione T, Gulko PS, Beeton C. KCa1.1 and Kv1.3 channels regulate the interactions between fibroblast-like synoviocytes and T lymphocytes during rheumatoid arthritis. Arthritis Res Ther. 2019;21:6.","journal-title":"Arthritis Res Ther"},{"key":"2800_CR6","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.cbpa.2017.02.015","volume":"38","author":"KG Chandy","year":"2017","unstructured":"Chandy KG, Norton RS. Peptide blockers of Kv1.3 channels in T cells as therapeutics for autoimmune disease. Curr Opin Chem Biol. 2017;38:97\u2013107.","journal-title":"Curr Opin Chem Biol"},{"key":"2800_CR7","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1080\/14728222.2017.1398234","volume":"21","author":"C Beeton","year":"2017","unstructured":"Beeton C. KCa1.1 channels as therapeutic targets for rheumatoid arthritis. Expert Opin Ther Targets. 2017;21:1077\u201381.","journal-title":"Expert Opin Ther Targets"},{"key":"2800_CR8","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1002\/art.38883","volume":"67","author":"MR Tanner","year":"2015","unstructured":"Tanner MR, Hu X, Huq R, Tajhya RB, Sun L, Khan FS, et al. KCa1.1 Inhibition attenuates fibroblast-like synoviocyte invasiveness and ameliorates disease in rat models of rheumatoid arthritis. Arthritis Rheumatol. 2015;67:96\u2013106.","journal-title":"Arthritis Rheumatol"},{"key":"2800_CR9","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1124\/jpet.117.245118","volume":"365","author":"MR Tanner","year":"2018","unstructured":"Tanner MR, Pennington MW, Chamberlain BH, Huq R, Gehrmann EJ, Laragione T, et al. Targeting KCa1.1 channels with a scorpion venom peptide for the therapy of rat models of rheumatoid arthritis. J Pharmacol Exp Ther. 2018;365:227\u201336.","journal-title":"J Pharmacol Exp Ther"},{"key":"2800_CR10","doi-asserted-by":"publisher","first-page":"11083","DOI":"10.1016\/S0021-9258(19)38560-6","volume":"265","author":"A Galvez","year":"1990","unstructured":"Galvez A, Gimenez-Gallego G, Reuben JP, Roy-Contancin L, Feigenbaum P, Kaczorowski GJ, et al. Purification and characterization of a unique, potent, peptidyl probe for the high conductance calcium-activated potassium channel from venom of the scorpion Buthus tamulus. J Biol Chem. 1990;265:11083\u201390.","journal-title":"J Biol Chem"},{"key":"2800_CR11","doi-asserted-by":"publisher","first-page":"5562","DOI":"10.1073\/pnas.100118597","volume":"97","author":"P Meera","year":"2000","unstructured":"Meera P, Wallner M, Toro L. A neuronal \u03b2 subunit (KCNMB4) makes the large conductance, voltage- and Ca2+-activated K+ channel resistant to charybdotoxin and iberiotoxin. Proc Natl Acad Sci USA. 2000;97:5562\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2800_CR12","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1021\/cr400031z","volume":"114","author":"M G\u00f3ngora-Ben\u00edtez","year":"2014","unstructured":"G\u00f3ngora-Ben\u00edtez M, Tulla-Puche J, Albericio F. Multifaceted roles of disulfide bonds. Peptides as therapeutics. Chem Rev. 2014;114:901\u201326.","journal-title":"Chem Rev"},{"key":"2800_CR13","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1080\/17460441.2017.1317243","volume":"12","author":"RS Norton","year":"2017","unstructured":"Norton RS. Enhancing the therapeutic potential of peptide toxins. Expert Opin Drug Discov. 2017;12:611\u201323.","journal-title":"Expert Opin Drug Discov"},{"key":"2800_CR14","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1126\/science.289.5483.1352","volume":"289","author":"L Steidler","year":"2000","unstructured":"Steidler L, Hans W, Schotte L, Neirynck S, Obermeier F, Falk W, et al. Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science. 2000;289:1352\u20135.","journal-title":"Science"},{"key":"2800_CR15","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.cels.2023.05.004","volume":"14","author":"AJ Triassi","year":"2023","unstructured":"Triassi AJ, Fields BD, Monahan CE, Means JM, Park Y, Doosthosseini H, et al. Redesign of an Escherichia coli Nissle treatment for phenylketonuria using insulated genomic landing pads and genetic circuits to reduce burden. Cell Syst. 2023;14:512\u201324.","journal-title":"Cell Syst"},{"key":"2800_CR16","doi-asserted-by":"publisher","first-page":"e00183","DOI":"10.1128\/mSphere.00183-20","volume":"5","author":"J-H Oh","year":"2020","unstructured":"Oh J-H, Schueler KL, Stapleton DS, Alexander LM, Yen C-LE, Keller MP, et al. Secretion of recombinant interleukin-22 by engineered Lactobacillus reuteri reduces fatty liver disease in a mouse model of diet-induced obesity. mSphere. 2020;5:e00183\u201320.","journal-title":"mSphere"},{"key":"2800_CR17","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.tim.2022.09.003","volume":"31","author":"LM Alexander","year":"2022","unstructured":"Alexander LM, van Pijkeren J-P. Modes of therapeutic delivery in synthetic microbiology. Trends Microbiol. 2022;31:197\u2013211.","journal-title":"Trends Microbiol"},{"key":"2800_CR18","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/j.tips.2022.08.002","volume":"43","author":"CW Woo","year":"2022","unstructured":"Woo CW, Tso P, Yiu JHC. Commensal gut microbiota-based strategies for oral delivery of therapeutic proteins. Trends Pharmacol Sci. 2022;43:1004\u201313.","journal-title":"Trends Pharmacol Sci"},{"key":"2800_CR19","doi-asserted-by":"publisher","first-page":"e2211977120","DOI":"10.1073\/pnas.2211977120","volume":"120","author":"Y Wang","year":"2023","unstructured":"Wang Y, Zhu D, Ortiz-Velez LC, Perry JL, Pennington MW, Hyser JM, et al. A bioengineered probiotic for the oral delivery of a peptide Kv1.3 channel blocker to treat rheumatoid arthritis. Proc Natl Acad Sci USA. 2023;120:e2211977120.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2800_CR20","doi-asserted-by":"publisher","first-page":"4645","DOI":"10.1073\/pnas.1000099107","volume":"108","author":"J Walter","year":"2011","unstructured":"Walter J, Britton RA, Roos S. Host-microbial symbiosis in the vertebrate gastrointestinal tract and the Lactobacillus reuteri paradigm. Proc Natl Acad Sci USA. 2011;108:4645\u201352.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2800_CR21","doi-asserted-by":"publisher","first-page":"8151","DOI":"10.1021\/bi00150a006","volume":"31","author":"BA Johnson","year":"1992","unstructured":"Johnson BA, Sugg EE. Determination of the three-dimensional structure of iberiotoxin in solution by proton nuclear magnetic resonance spectroscopy. Biochemistry. 1992;31:8151\u20139.","journal-title":"Biochemistry"},{"key":"2800_CR22","doi-asserted-by":"publisher","first-page":"529","DOI":"10.3390\/md13010529","volume":"13","author":"MW Pennington","year":"2015","unstructured":"Pennington MW, Chang SC, Chauhan S, Huq R, Tajhya RB, Chhabra S, et al. Development of highly selective Kv1.3-blocking peptides based on the sea anemone peptide ShK. Mar Drugs. 2015;13:529\u201342.","journal-title":"Mar Drugs"},{"key":"2800_CR23","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s004380050315","volume":"253","author":"K Leenhouts","year":"1996","unstructured":"Leenhouts K, Buist G, Bolhuis A, ten Berge A, Kiel J, Mierau I, et al. A general system for generating unlabelled gene replacements in bacterial chromosomes. Mol Gen Genet. 1996;253:217\u201324.","journal-title":"Mol Gen Genet"},{"key":"2800_CR24","doi-asserted-by":"crossref","unstructured":"van Asseldonk M, Rutten G, Oteman M, Siezen RJ, de Vos WM, Simons G. Cloning of usp45, a gene encoding a secreted protein from Lactococcus lactis subsp. lactis MG1363. Gene. 1990;95:155\u201360.","DOI":"10.1016\/0378-1119(90)90428-T"},{"key":"2800_CR25","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1093\/nar\/28.1.292","volume":"28","author":"Y Nakamura","year":"2000","unstructured":"Nakamura Y, Gojobori T, Ikemura T. Codon usage tabulated from international DNA sequence databases: status for the year 2000. Nucleic Acids Res. 2000;28:292.","journal-title":"Nucleic Acids Res"},{"key":"2800_CR26","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1099\/mic.0.28084-0","volume":"151","author":"E S\u00f8rvig","year":"2005","unstructured":"S\u00f8rvig E, Mathiesen G, Naterstad K, Eijsink VGH, Axelsson L. High-level, inducible gene expression in Lactobacillus sakei and Lactobacillus plantarum using versatile expression vectors. Microbiology. 2005;151:2439\u201349.","journal-title":"Microbiology"},{"key":"2800_CR27","doi-asserted-by":"crossref","unstructured":"Mathiesen G, Axelsson L, Eijsink VGH. Heterologous protein production in Lactobacillus (plantarum) using pSIP vectors. In: Garcia Fruit\u00f3s E, Ar\u00eds Giralt A, editors. Insoluble proteins: methods and protocols. New York, NY: Springer US; 2022. pp. 205\u201317.","DOI":"10.1007\/978-1-0716-1859-2_12"},{"key":"2800_CR28","doi-asserted-by":"crossref","unstructured":"Green MR, Sambrook J. Transformation of Escherichia coli by electroporation. Cold Spring Harb Protoc. 2020;232\u20138.","DOI":"10.1101\/pdb.prot101220"},{"key":"2800_CR29","doi-asserted-by":"publisher","first-page":"3119","DOI":"10.1128\/aem.55.12.3119-3123.1989","volume":"55","author":"H Holo","year":"1989","unstructured":"Holo H, Nes IF. High-Frequency transformation, by electroporation, of Lactococcus lactis subsp. cremoris grown with glycine in osmotically stabilized media. Appl Environ Microbiol. 1989;55:3119\u201323.","journal-title":"Appl Environ Microbiol"},{"key":"2800_CR30","doi-asserted-by":"crossref","unstructured":"Duggan A, McMillen D. Methods for electroporation and transformation confirmation in Limosilactobacillus reuteri DSM20016. J Vis Exp. 2023;e65463.","DOI":"10.3791\/65463"},{"key":"2800_CR31","doi-asserted-by":"crossref","unstructured":"Beeton C, Garcia A, Chandy KG. Drawing blood from rats through the saphenous vein and by cardiac puncture. J Vis Exp. 2007;e266.","DOI":"10.3791\/266-v"},{"key":"2800_CR32","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1021\/bc060002u","volume":"17","author":"J-P Bingham","year":"2006","unstructured":"Bingham J-P, Bian S, Tan Z-Y, Takacs Z, Moczydlowski E. Synthesis of a biotin derivative of iberiotoxin: binding interactions with streptavidin and the BK Ca2+-Activated K+ channel expressed in a human cell line. Bioconjug Chem. 2006;17:689\u201399.","journal-title":"Bioconjug Chem"},{"key":"2800_CR33","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1124\/jpet.112.191890","volume":"342","author":"EJ Tarcha","year":"2012","unstructured":"Tarcha EJ, Chi V, Mu\u00f1oz-El\u00edas EJ, Bailey D, Londono LM, Upadhyay SK, et al. Durable pharmacological responses from the peptide ShK-186, a specific Kv1.3 channel inhibitor that suppresses T cell mediators of autoimmune disease. J Pharmacol Exp Ther. 2012;342:642\u201353.","journal-title":"J Pharmacol Exp Ther"},{"key":"2800_CR34","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.clim.2017.03.014","volume":"180","author":"MR Tanner","year":"2017","unstructured":"Tanner MR, Tajhya RB, Huq R, Gehrmann EJ, Rodarte KE, Atik MA, et al. Prolonged immunomodulation in inflammatory arthritis using the selective Kv1.3 channel blocker HsTX1[R14A] and its PEGylated analog. Clin Immunol. 2017;180:45\u201357.","journal-title":"Clin Immunol"},{"key":"2800_CR35","doi-asserted-by":"publisher","first-page":"9928","DOI":"10.1074\/jbc.M212868200","volume":"278","author":"C Beeton","year":"2003","unstructured":"Beeton C, Wulff H, Singh S, Botsko S, Crossley G, Gutman GA, et al. A novel fluorescent toxin to detect and investigate Kv1.3 channel up-regulation in chronically activated T lymphocytes. J Biol Chem. 2003;278:9928\u201337.","journal-title":"J Biol Chem"},{"key":"2800_CR36","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1177\/0004563217707783","volume":"55","author":"C Trambas","year":"2018","unstructured":"Trambas C, Lu Z, Yen T, Sikaris K. Depletion of biotin using streptavidin-coated microparticles: a validated solution to the problem of biotin interference in streptavidin\u2013biotin immunoassays. Ann Clin Biochem. 2018;55:216\u201326.","journal-title":"Ann Clin Biochem"},{"key":"2800_CR37","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/j.1365-263X.2009.00989.x","volume":"19","author":"E \u00c7aglar","year":"2009","unstructured":"\u00c7aglar E, Topcuoglu N, \u00c7ildir SK, Sandalli N, Kulekci G. Oral colonization by Lactobacillus reuteri ATCC 55730 after exposure to probiotics. Int J Paediatr Dent. 2009;19:377\u201381.","journal-title":"Int J Paediatr Dent"},{"key":"2800_CR38","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1002\/art.20782","volume":"52","author":"M Brenner","year":"2005","unstructured":"Brenner M, Meng H-C, Yarlett NC, Griffiths MM, Remmers EF, Wilder RL, et al. The non\u2013major histocompatibility complex quantitative trait locus Cia10 contains a major arthritis gene and regulates disease severity, pannus formation, and joint damage. Arthritis Rheum. 2005;52:322\u201332.","journal-title":"Arthritis Rheum"},{"key":"2800_CR39","doi-asserted-by":"crossref","unstructured":"Beeton C, Chandy KG. Induction and monitoring of active delayed type hypersensitivity (DTH) in rats. J Vis Exp. 2007;e237.","DOI":"10.3791\/237"},{"key":"2800_CR40","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1172\/JCI16921","volume":"111","author":"H Wulff","year":"2003","unstructured":"Wulff H, Calabresi PA, Allie R, Yun S, Pennington M, Beeton C, et al. The voltage-gated Kv1.3 K+ channel in effector memory T cells as new target for MS. J Clin Invest. 2003;111:1703\u201313.","journal-title":"J Clin Invest"},{"key":"2800_CR41","doi-asserted-by":"publisher","first-page":"776","DOI":"10.4049\/jimmunol.173.2.776","volume":"173","author":"H Wulff","year":"2004","unstructured":"Wulff H, Knaus H-G, Pennington M, Chandy KG. K+ channel expression during B cell differentiation: implications for immunomodulation and autoimmunity. J Immunol. 2004;173:776\u201386.","journal-title":"J Immunol"},{"key":"2800_CR42","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1006\/clin.1994.1164","volume":"73","author":"FH Duris","year":"1994","unstructured":"Duris FH, Fava RA, Noelle RJ. Collagen-induced arthritis as a model of rheumatoid arthritis. Clin Immunol Immunopathol. 1994;73:11\u20138.","journal-title":"Clin Immunol Immunopathol"},{"key":"2800_CR43","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/BF01871932","volume":"103","author":"EK Gallin","year":"1988","unstructured":"Gallin EK, McKinney LC. Patch-clamp studies in human macrophages: single-channel and whole-cell characterization of two K+ conductances. J Membr Biol. 1988;103:55\u201366.","journal-title":"J Membr Biol"},{"key":"2800_CR44","doi-asserted-by":"publisher","first-page":"e01197","DOI":"10.1128\/mbio.01197-23","volume":"14","author":"IY Choi","year":"2023","unstructured":"Choi IY, Oh J-H, Wang Z, van Pijkeren J-P. Bioluminescent monitoring of recombinant lactic acid bacteria and their products. mBio. 2023;14:e01197\u201323.","journal-title":"mBio"},{"key":"2800_CR45","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1124\/mol.104.008193","volume":"67","author":"C Beeton","year":"2005","unstructured":"Beeton C, Pennington MW, Wulff H, Singh S, Nugent D, Crossley G, et al. Targeting effector memory T cells with a selective peptide inhibitor of Kv1.3 channels for therapy of autoimmune diseases. Mol Pharmacol. 2005;67:1369\u201381.","journal-title":"Mol Pharmacol"},{"key":"2800_CR46","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1046\/j.1472-765X.2003.01360.x","volume":"37","author":"L Axelsson","year":"2003","unstructured":"Axelsson L, Lindstad G, Naterstad K. Development of an inducible gene expression system for Lactobacillus sakei. Lett Appl Microbiol. 2003;37:115\u201320.","journal-title":"Lett Appl Microbiol"},{"key":"2800_CR47","doi-asserted-by":"crossref","unstructured":"Karimi S, Ahl D, V\u00e5gesj\u00f6 E, Holm L, Phillipson M, Jonsson H et al. In vivo and in vitro detection of luminescent and fluorescent Lactobacillus reuteri and application of red fluorescent mCherry for assessing plasmid persistence. PLoS One. 2016;11:e0151969.","DOI":"10.1371\/journal.pone.0151969"},{"key":"2800_CR48","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1046\/j.1472-765X.2002.01171.x","volume":"35","author":"R de Waard","year":"2002","unstructured":"de Waard R, Garssen J, Vos JG, Claassen E. Modulation of delayed-type hypersensitivity and acquired cellular resistance by orally administered viable indigenous lactobacilli in Listeria monocytogenes infected Wistar rats. Lett Appl Microbiol. 2002;35:256\u201360.","journal-title":"Lett Appl Microbiol"},{"key":"2800_CR49","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/nsb0496-317","volume":"3","author":"JE Tudor","year":"1996","unstructured":"Tudor JE, Pallaghy PK, Pennington MW, Norton RS. Solution structure of ShK toxin, a novel potassium channel inhibitor from a sea anemone. Nat Struct Biol. 1996;3:317\u201320.","journal-title":"Nat Struct Biol"},{"key":"2800_CR50","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1002\/(SICI)1097-0029(20000515)49:4<346::AID-JEMT3>3.0.CO;2-B","volume":"49","author":"E Ziv","year":"2000","unstructured":"Ziv E, Bendayan M. Intestinal absorption of peptides through the enterocytes. Microsc Res Tech. 2000;49:346\u201352.","journal-title":"Microsc Res Tech"},{"key":"2800_CR51","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/s41578-019-0156-6","volume":"5","author":"TD Brown","year":"2020","unstructured":"Brown TD, Whitehead KA, Mitragotri S. Materials for oral delivery of proteins and peptides. Nat Rev Mater. 2020;5:127\u201348.","journal-title":"Nat Rev Mater"},{"key":"2800_CR52","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1099\/mic.0.073551-0","volume":"160","author":"H Jensen","year":"2014","unstructured":"Jensen H, Roos S, Jonsson H, Rud I, Grimmer S, van Pijkeren J-P, et al. Role of Lactobacillus reuteri cell and mucus-binding protein A (CmbA) in adhesion to intestinal epithelial cells and mucus in vitro. Microbiology. 2014;160:671\u201381.","journal-title":"Microbiology"},{"key":"2800_CR53","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1021\/acssynbio.9b00356","volume":"9","author":"ZJS Mays","year":"2020","unstructured":"Mays ZJS, Chappell TC, Nair NU. Quantifying and engineering mucus adhesion of probiotics. ACS Synth Biol. 2020;9:356\u201367.","journal-title":"ACS Synth Biol"},{"key":"2800_CR54","doi-asserted-by":"publisher","first-page":"4509","DOI":"10.1038\/srep04509","volume":"4","author":"MH Rashid","year":"2014","unstructured":"Rashid MH, Huq R, Tanner MR, Chhabra S, Khoo KK, Estrada R, et al. A potent and Kv1.3-selective analogue of the scorpion toxin HsTX1 as a potential therapeutic for autoimmune diseases. Sci Rep. 2014;4:4509.","journal-title":"Sci Rep"},{"key":"2800_CR55","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1016\/j.xphs.2016.05.008","volume":"105","author":"L Jin","year":"2016","unstructured":"Jin L, Boyd BJ, Larson IC, Pennington MW, Norton RS, Nicolazzo JA. Enabling noninvasive systemic delivery of the Kv1.3-blocking peptide HsTX1[R14A] via the buccal mucosa. J Pharm Sci. 2016;105:2173\u20139.","journal-title":"J Pharm Sci"},{"key":"2800_CR56","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1136\/gutjnl-2018-317726","volume":"69","author":"J Tulkens","year":"2020","unstructured":"Tulkens J, Vergauwen G, Deun JV, Geeurickx E, Dhondt B, Lippens L, et al. Increased levels of systemic LPS-positive bacterial extracellular vesicles in patients with intestinal barrier dysfunction. Gut. 2020;69:191\u20133.","journal-title":"Gut"},{"key":"2800_CR57","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.tim.2021.12.012","volume":"30","author":"A Hendrix","year":"2022","unstructured":"Hendrix A, Wever OD. Systemically circulating bacterial extracellular vesicles: origin, fate, and function. Trends Microbiol. 2022;30:213\u20136.","journal-title":"Trends Microbiol"}],"container-title":["Microbial Cell Factories"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12934-025-02800-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12934-025-02800-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12934-025-02800-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T13:14:28Z","timestamp":1757337268000},"score":1,"resource":{"primary":{"URL":"https:\/\/microbialcellfactories.biomedcentral.com\/articles\/10.1186\/s12934-025-02800-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,2]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2800"],"URL":"https:\/\/doi.org\/10.1186\/s12934-025-02800-2","relation":{},"ISSN":["1475-2859"],"issn-type":[{"value":"1475-2859","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,2]]},"assertion":[{"value":"28 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiment protocols were approved by the Institutional Animal Care and Use Committee at Baylor College of Medicine.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"CB is an inventor on the patent protecting ShK-186, currently in clinical trials for the treatment of autoimmune diseases. CB and RAB are inventors on a patent disclosure protecting LrS235. RAB is a cofounder of Mikrovia and PanaBio.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"177"}}